Bliss GVS Pharma (BLISSGVS.BO) Earnings Analysis

Bliss GVS Pharma (BLISSGVS.BO) has no confirmed upcoming earnings date. Trailing P/E 38.25.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does BLISSGVS.BO next report earnings?

No confirmed upcoming earnings date is currently scheduled for BLISSGVS.BO. This page updates as the calendar is published.

BLISSGVS.BO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-113.27 INRn/an/an/a
2026-01-262.2 INRn/an/an/a
2025-10-222.54 INRn/an/an/a
2025-07-224.04 INRn/an/an/a
2025-05-121.46 INRn/an/an/a
2025-01-282.27 INRn/an/an/a
2024-10-242.29 INRn/an/an/a
2024-07-241.93 INRn/an/an/a

BLISSGVS.BO valuation and analyst view

Trailing P/E38.25
Trailing EPS11.869 INR
Price / book4.23
Dividend yield0.32%
Market cap46.88B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Bliss GVS Pharma (BLISSGVS.BO)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for BLISSGVS.BO. This page updates as the calendar is published.

Did BLISSGVS.BO beat earnings last quarter?

Consensus estimate data was not available for BLISSGVS.BO's 2026-05-11 report.

What is BLISSGVS.BO's current P/E ratio and EPS?

BLISSGVS.BO trades at a trailing P/E of 38.25 on trailing EPS of 11.86932666362448 INR.

What do analysts rate BLISSGVS.BO?

BLISSGVS.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.